CN102178804A - 一种治疗肛周湿疹的中药组合物及其制备方法 - Google Patents
一种治疗肛周湿疹的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN102178804A CN102178804A CN2011101074827A CN201110107482A CN102178804A CN 102178804 A CN102178804 A CN 102178804A CN 2011101074827 A CN2011101074827 A CN 2011101074827A CN 201110107482 A CN201110107482 A CN 201110107482A CN 102178804 A CN102178804 A CN 102178804A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- fructus
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 64
- 208000010668 atopic eczema Diseases 0.000 title claims abstract description 60
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims description 37
- 239000003814 drug Substances 0.000 claims abstract description 183
- 239000004863 Frankincense Substances 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims abstract description 17
- 241000931705 Cicada Species 0.000 claims abstract description 7
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 7
- 229940079593 drug Drugs 0.000 claims description 56
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 45
- 239000000843 powder Substances 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 239000000243 solution Substances 0.000 claims description 23
- 238000010438 heat treatment Methods 0.000 claims description 22
- 241000628997 Flos Species 0.000 claims description 19
- 239000002674 ointment Substances 0.000 claims description 18
- 210000000582 semen Anatomy 0.000 claims description 18
- 241000717739 Boswellia sacra Species 0.000 claims description 17
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 17
- 238000000605 extraction Methods 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- 241000756943 Codonopsis Species 0.000 claims description 13
- 238000010992 reflux Methods 0.000 claims description 11
- 238000002481 ethanol extraction Methods 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 239000007766 cera flava Substances 0.000 claims description 8
- -1 sublimed preparation Substances 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 7
- 229940098465 tincture Drugs 0.000 claims description 7
- 241000245240 Lonicera Species 0.000 claims description 6
- 241000207929 Scutellaria Species 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 235000012907 honey Nutrition 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 235000008504 concentrate Nutrition 0.000 claims description 5
- 238000001802 infusion Methods 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 230000006837 decompression Effects 0.000 claims description 4
- 235000011837 pasties Nutrition 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000013040 bath agent Substances 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 3
- 239000000469 ethanolic extract Substances 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims description 3
- 239000011505 plaster Substances 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 239000000829 suppository Substances 0.000 claims description 3
- 229940099259 vaseline Drugs 0.000 claims description 3
- 239000008298 dragée Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 70
- 210000004369 blood Anatomy 0.000 abstract description 69
- 208000003251 Pruritus Diseases 0.000 abstract description 65
- 230000000694 effects Effects 0.000 abstract description 63
- 230000001737 promoting effect Effects 0.000 abstract description 25
- 238000001035 drying Methods 0.000 abstract description 15
- 230000017531 blood circulation Effects 0.000 abstract description 13
- 230000007803 itching Effects 0.000 abstract description 11
- 235000013399 edible fruits Nutrition 0.000 abstract description 6
- 241000411851 herbal medicine Species 0.000 abstract description 6
- 230000001976 improved effect Effects 0.000 abstract description 5
- 244000290970 Tetrapanax papyrifer Species 0.000 abstract description 4
- 230000008338 local blood flow Effects 0.000 abstract description 4
- 230000004856 capillary permeability Effects 0.000 abstract description 3
- 230000001926 lymphatic effect Effects 0.000 abstract description 3
- 229940037003 alum Drugs 0.000 abstract description 2
- 230000003902 lesion Effects 0.000 abstract description 2
- 241000132012 Atractylodes Species 0.000 abstract 2
- 241000951473 Schizonepeta Species 0.000 abstract 2
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 abstract 1
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000130781 Arnebia Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 241000212948 Cnidium Species 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 241000972672 Phellodendron Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- 239000008492 tangshen Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 43
- 201000010099 disease Diseases 0.000 description 42
- 208000002193 Pain Diseases 0.000 description 34
- 230000036407 pain Effects 0.000 description 33
- 241001465754 Metazoa Species 0.000 description 30
- 238000012360 testing method Methods 0.000 description 25
- 210000003734 kidney Anatomy 0.000 description 24
- 210000000952 spleen Anatomy 0.000 description 24
- 241000700199 Cavia porcellus Species 0.000 description 20
- 230000001717 pathogenic effect Effects 0.000 description 20
- 230000007812 deficiency Effects 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 18
- 238000000034 method Methods 0.000 description 17
- 241000699670 Mus sp. Species 0.000 description 15
- 235000009508 confectionery Nutrition 0.000 description 15
- 229960004756 ethanol Drugs 0.000 description 15
- 231100000614 poison Toxicity 0.000 description 15
- 230000001154 acute effect Effects 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 14
- 206010015150 Erythema Diseases 0.000 description 13
- 206010040882 skin lesion Diseases 0.000 description 13
- 231100000444 skin lesion Toxicity 0.000 description 13
- 208000006820 Arthralgia Diseases 0.000 description 12
- 206010007247 Carbuncle Diseases 0.000 description 12
- 206010040943 Skin Ulcer Diseases 0.000 description 12
- 230000003628 erosive effect Effects 0.000 description 12
- 231100000321 erythema Toxicity 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 206010030113 Oedema Diseases 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 231100000019 skin ulcer Toxicity 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 11
- 230000008961 swelling Effects 0.000 description 11
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 10
- 210000000436 anus Anatomy 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 208000001848 dysentery Diseases 0.000 description 10
- 230000003203 everyday effect Effects 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 210000002216 heart Anatomy 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- 206010012735 Diarrhoea Diseases 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 9
- 239000010839 body fluid Substances 0.000 description 9
- 230000037396 body weight Effects 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 206010037844 rash Diseases 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- 230000001225 therapeutic effect Effects 0.000 description 9
- 239000003440 toxic substance Substances 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 210000001015 abdomen Anatomy 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 244000052769 pathogen Species 0.000 description 8
- 206010010774 Constipation Diseases 0.000 description 7
- 206010020751 Hypersensitivity Diseases 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 206010023126 Jaundice Diseases 0.000 description 7
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 7
- 206010040880 Skin irritation Diseases 0.000 description 7
- 206010000496 acne Diseases 0.000 description 7
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 7
- 229960003321 baicalin Drugs 0.000 description 7
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 230000001047 pyretic effect Effects 0.000 description 7
- 231100000475 skin irritation Toxicity 0.000 description 7
- 230000036556 skin irritation Effects 0.000 description 7
- 210000002700 urine Anatomy 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 6
- 208000000059 Dyspnea Diseases 0.000 description 6
- 206010013975 Dyspnoeas Diseases 0.000 description 6
- 208000008454 Hyperhidrosis Diseases 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 6
- 206010040844 Skin exfoliation Diseases 0.000 description 6
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 6
- 208000033809 Suppuration Diseases 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 229960003291 chlorphenamine Drugs 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 206010022437 insomnia Diseases 0.000 description 6
- 230000002147 killing effect Effects 0.000 description 6
- 229940023488 pill Drugs 0.000 description 6
- 208000037920 primary disease Diseases 0.000 description 6
- 201000005404 rubella Diseases 0.000 description 6
- 208000017520 skin disease Diseases 0.000 description 6
- 206010040872 skin infection Diseases 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 231100001274 therapeutic index Toxicity 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 210000001835 viscera Anatomy 0.000 description 6
- 206010048768 Dermatosis Diseases 0.000 description 5
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- 201000005505 Measles Diseases 0.000 description 5
- 208000002474 Tinea Diseases 0.000 description 5
- 241000130764 Tinea Species 0.000 description 5
- 208000026935 allergic disease Diseases 0.000 description 5
- 230000007815 allergy Effects 0.000 description 5
- 238000010171 animal model Methods 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 201000005884 exanthem Diseases 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 229960001340 histamine Drugs 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 230000010354 integration Effects 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000002269 spontaneous effect Effects 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 210000003932 urinary bladder Anatomy 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 206010063409 Acarodermatitis Diseases 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010030302 Oliguria Diseases 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 208000004680 Rectal Fistula Diseases 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 206010039509 Scab Diseases 0.000 description 4
- 241000447727 Scabies Species 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 208000019790 abdominal distention Diseases 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 206010002156 anal fistula Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 208000013116 chronic cough Diseases 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 230000035618 desquamation Effects 0.000 description 4
- 208000013219 diaphoresis Diseases 0.000 description 4
- 206010013990 dysuria Diseases 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 230000003211 malignant effect Effects 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 210000000664 rectum Anatomy 0.000 description 4
- 238000007670 refining Methods 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 208000005687 scabies Diseases 0.000 description 4
- 210000004706 scrotum Anatomy 0.000 description 4
- 230000007958 sleep Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 208000016583 Anus disease Diseases 0.000 description 3
- 208000007163 Dermatomycoses Diseases 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 208000001140 Night Blindness Diseases 0.000 description 3
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000588769 Proteus <enterobacteria> Species 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 208000012886 Vertigo Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000001142 anti-diarrhea Effects 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 208000019902 chronic diarrheal disease Diseases 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 201000003929 dermatomycosis Diseases 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 208000017561 flaccidity Diseases 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 231100000682 maximum tolerated dose Toxicity 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 230000001314 paroxysmal effect Effects 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 230000002085 persistent effect Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 229960000502 poloxamer Drugs 0.000 description 3
- 229920001983 poloxamer Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 231100000820 toxicity test Toxicity 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- 231100000889 vertigo Toxicity 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 206010002153 Anal fissure Diseases 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 208000009531 Fissure in Ano Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010035148 Plague Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 241001312524 Streptococcus viridans Species 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 241000223238 Trichophyton Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 206010046742 Urticaria contact Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000005784 autoimmunity Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000002951 depilatory effect Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 208000010643 digestive system disease Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000007368 endocrine function Effects 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 238000003958 fumigation Methods 0.000 description 2
- 208000001786 gonorrhea Diseases 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 229940100691 oral capsule Drugs 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 2
- 230000032696 parturition Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 2
- 238000006748 scratching Methods 0.000 description 2
- 230000002393 scratching effect Effects 0.000 description 2
- 231100000022 skin irritation / corrosion Toxicity 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 210000003905 vulva Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- 241001521511 Albizia kalkora Species 0.000 description 1
- 206010068172 Anal pruritus Diseases 0.000 description 1
- 208000019751 Anorectal disease Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000255791 Bombyx Species 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000589562 Brucella Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000127225 Enceliopsis nudicaulis Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 206010024438 Lichenification Diseases 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 240000003146 Lobelia chinensis Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000027530 Meniere disease Diseases 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000193418 Paenibacillus larvae Species 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 206010033888 Paraphilia Diseases 0.000 description 1
- 206010033971 Paratyphoid fever Diseases 0.000 description 1
- 244000137852 Petrea volubilis Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000009544 Pruritus Ani Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 208000015815 Rectal disease Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010039705 Scleritis Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 240000005498 Setaria italica Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010040867 Skin hypertrophy Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 206010041954 Starvation Diseases 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 229910052934 alunite Inorganic materials 0.000 description 1
- 239000010424 alunite Substances 0.000 description 1
- CKMXBZGNNVIXHC-UHFFFAOYSA-L ammonium magnesium phosphate hexahydrate Chemical compound [NH4+].O.O.O.O.O.O.[Mg+2].[O-]P([O-])([O-])=O CKMXBZGNNVIXHC-UHFFFAOYSA-L 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003716 antitrichomonal agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 229940088529 claritin Drugs 0.000 description 1
- 210000003029 clitoris Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000009989 contractile response Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 229940041984 dextran 1 Drugs 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007971 neurological deficit Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 235000002252 panizo Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 150000003118 prednisones Chemical class 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000013138 pruning Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 229930193195 schizandrin Natural products 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 229910052567 struvite Inorganic materials 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- KPZTWMNLAFDTGF-UHFFFAOYSA-D trialuminum;potassium;hexahydroxide;disulfate Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O KPZTWMNLAFDTGF-UHFFFAOYSA-D 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 1
- 239000009571 yupingfeng Substances 0.000 description 1
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical compound [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 剂量 | 动物数 | 瘙痒次数 | 瘙痒持续时间(秒) |
空白对照 | 10 | 28.8±6.7 | 164.5±30.5 | |
扑尔敏 | 4mg/kg | 10 | 6.5±3.6*** | 12.1±3.3*** |
乌蛇止痒丸 | 2g/kg | 10 | 11.7±6.1*** | 34.0±15.6*** |
本发明药物低剂量组 | 4.5g/kg | 10 | 23.2±4.6* | 64.8±31.6* |
本发明药物高剂量组 | 9g/kg | 10 | 20.2±3.7*** | 55.7±32.1*** |
组别 | 剂量 | 动物数 | 致痒阈(组胺总量,μg) |
空白对照组 | 10 | 57.0±95.1 | |
扑尔敏 | 4mg/kg | 10 | 237.9±47.4*** |
乌蛇止痒丸 | 1g/kg | 10 | 181.0±106.7** |
本发明药物低剂量组 | 2.3g/kg | 10 | 155.0±102.4* |
本发明药物高剂量组 | 4.5g/kg | 10 | 208.3±86.8*** |
组别 | n | 痊愈 | 显效 | 有效 | 无效 | 总有效率 |
治疗组 | 60 | 55(91. 67)* | 2(3.33) | 2(3.33) | 1(1.67) | 98. 33# |
对照组 | 40 | 25(62. 50) | 6(15) | 4(10) | 5(12.5) | 87.5 |
组别 | 皮损范围 | 皮损程度 | 瘙痒程度 | 瘙痒持续时间 |
治疗组 | 8. 43 ±3.79 * | 8. 84 ±4.32 * | 8. 45 ±3.95 * | 9. 16±6.24* |
对照组 | 6. 45 ±3.22 | 6. 42 ±3.27 | 5. 67 ±4.28 | 7. 47 ±4.83 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110107482A CN102178804B (zh) | 2011-04-28 | 2011-04-28 | 一种治疗肛周湿疹的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110107482A CN102178804B (zh) | 2011-04-28 | 2011-04-28 | 一种治疗肛周湿疹的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102178804A true CN102178804A (zh) | 2011-09-14 |
CN102178804B CN102178804B (zh) | 2012-10-03 |
Family
ID=44565210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110107482A Expired - Fee Related CN102178804B (zh) | 2011-04-28 | 2011-04-28 | 一种治疗肛周湿疹的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102178804B (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102327460A (zh) * | 2011-09-23 | 2012-01-25 | 隋玉兰 | 一种治疗湿疹的药剂 |
CN102488851A (zh) * | 2011-12-28 | 2012-06-13 | 张志远 | 治疗反复发作生殖器疱疹的药物及其制备方法 |
CN103006881A (zh) * | 2012-11-14 | 2013-04-03 | 原晓红 | 治疗湿疹的中药汤剂 |
CN103230480A (zh) * | 2013-04-10 | 2013-08-07 | 王秀刚 | 一种治疗血虚挟风型***湿疹的中药 |
CN103341097A (zh) * | 2013-07-09 | 2013-10-09 | 陈静静 | 治疗湿疹的中药配方 |
CN103751663A (zh) * | 2013-12-30 | 2014-04-30 | 青岛恒波仪器有限公司 | 一种治疗肛周湿疹的中药外用制剂及其制备方法 |
CN104013751A (zh) * | 2014-06-12 | 2014-09-03 | 沈莉芬 | 一种中药湿疹膏 |
CN106038835A (zh) * | 2016-06-28 | 2016-10-26 | 农雪梅 | 一种治疗湿疹的植物外用洗液及其制备方法 |
CN111759926A (zh) * | 2020-08-18 | 2020-10-13 | 江苏卫健信息科技有限公司 | 一种治疗急性湿疹的中药组合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1562294A (zh) * | 2004-03-25 | 2005-01-12 | 李振举 | 一种杀菌消毒治疗肛周病的中药组合物 |
CN101455738A (zh) * | 2009-01-05 | 2009-06-17 | 张姝梅 | 一种治疗湿疹的中药组合物及其制备方法 |
CN101647893A (zh) * | 2009-09-11 | 2010-02-17 | 张宪英 | 一种治疗肛周湿疹的中药洗剂 |
-
2011
- 2011-04-28 CN CN201110107482A patent/CN102178804B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1562294A (zh) * | 2004-03-25 | 2005-01-12 | 李振举 | 一种杀菌消毒治疗肛周病的中药组合物 |
CN101455738A (zh) * | 2009-01-05 | 2009-06-17 | 张姝梅 | 一种治疗湿疹的中药组合物及其制备方法 |
CN101647893A (zh) * | 2009-09-11 | 2010-02-17 | 张宪英 | 一种治疗肛周湿疹的中药洗剂 |
Non-Patent Citations (1)
Title |
---|
《广东医学》 19651231 曾春 皮肤湿疹的治疗 第25页 1-10 , 第03期 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102327460A (zh) * | 2011-09-23 | 2012-01-25 | 隋玉兰 | 一种治疗湿疹的药剂 |
CN102327460B (zh) * | 2011-09-23 | 2013-05-01 | 段雯 | 一种治疗湿疹的药剂 |
CN102488851A (zh) * | 2011-12-28 | 2012-06-13 | 张志远 | 治疗反复发作生殖器疱疹的药物及其制备方法 |
CN103006881A (zh) * | 2012-11-14 | 2013-04-03 | 原晓红 | 治疗湿疹的中药汤剂 |
CN103230480A (zh) * | 2013-04-10 | 2013-08-07 | 王秀刚 | 一种治疗血虚挟风型***湿疹的中药 |
CN103230480B (zh) * | 2013-04-10 | 2014-06-25 | 王秀刚 | 一种治疗血虚挟风型***湿疹的中药 |
CN103341097A (zh) * | 2013-07-09 | 2013-10-09 | 陈静静 | 治疗湿疹的中药配方 |
CN103751663A (zh) * | 2013-12-30 | 2014-04-30 | 青岛恒波仪器有限公司 | 一种治疗肛周湿疹的中药外用制剂及其制备方法 |
CN103751663B (zh) * | 2013-12-30 | 2016-06-29 | 杨高林 | 一种治疗肛周湿疹的中药外用制剂及其制备方法 |
CN104013751A (zh) * | 2014-06-12 | 2014-09-03 | 沈莉芬 | 一种中药湿疹膏 |
CN106038835A (zh) * | 2016-06-28 | 2016-10-26 | 农雪梅 | 一种治疗湿疹的植物外用洗液及其制备方法 |
CN111759926A (zh) * | 2020-08-18 | 2020-10-13 | 江苏卫健信息科技有限公司 | 一种治疗急性湿疹的中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN102178804B (zh) | 2012-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048894B (zh) | 一种治疗烧伤的中药组合物及其制备方法 | |
CN102178804B (zh) | 一种治疗肛周湿疹的中药组合物及其制备方法 | |
CN102145064B (zh) | 一种治疗老年性***炎的中药组合物及其制备方法 | |
CN101804166B (zh) | 一种治疗小儿皮炎湿疹的中药组合物 | |
CN103721131B (zh) | 一种治疗妇女慢性***的中药栓剂及其制备方法 | |
CN102145111B (zh) | 一种治疗霉菌性***炎的中药组合物及其制备方法 | |
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN103041173A (zh) | 一种治疗皮炎、湿疹的中药外用制剂及其制备方法 | |
CN101455738A (zh) | 一种治疗湿疹的中药组合物及其制备方法 | |
CN101518600B (zh) | 一种治疗细菌或真菌性皮肤病的中药组合物及其制备方法 | |
CN103751663A (zh) | 一种治疗肛周湿疹的中药外用制剂及其制备方法 | |
CN102178814B (zh) | 一种治疗滴虫性***炎的中药组合物及其制备方法 | |
CN103800772A (zh) | 一种防治***炎症的妇科外用洗液及其制备方法 | |
CN103860978B (zh) | 一种治疗褥疮的中药制剂及其制备方法 | |
CN102058715B (zh) | 一种治疗慢性***炎的中药制剂及其制备方法 | |
CN102178877B (zh) | 一种治疗阴囊湿疹的外用制剂及其制备方法 | |
CN104274788A (zh) | 一种治疗妇女肝火湿热型带下的中药组合物及其制备方法 | |
CN102000164B (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
CN102178818B (zh) | 一种治疗乳腺癌的中药组合物及其制备方法 | |
CN104906465A (zh) | 一种治疗妇女慢性***的中药化瘀组合物及其制备方法 | |
CN102846824B (zh) | 一种治疗寒湿血瘀阻络型糖尿病足的中药组合物及其制备方法 | |
CN104147538A (zh) | 一种治疗湿热毒盛型糖尿病足的中药制剂及其制备方法 | |
CN102178781B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
CN103041247A (zh) | 一种治疗***炎的中药栓剂及其制备方法 | |
CN104958633A (zh) | 一种治疗寻常性痤疮的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NANTONG WEEK TOURISM DEVELOPMENT CO., LTD. Free format text: FORMER OWNER: KONG JIAN Effective date: 20130807 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 264006 YANTAI, SHANDONG PROVINCE TO: 226121 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130807 Address after: 226121 Jiangsu province Nantong markets three factory town Road No. 79 Patentee after: Nantong seven Tourism Development Co., Ltd. Address before: 264006 No. 92, Yantai economic and Technological Development Zone, Shandong, Zhujianglu Road Patentee before: Kong Jian |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121003 Termination date: 20180428 |
|
CF01 | Termination of patent right due to non-payment of annual fee |